Sitonce
Country: US
Show exams for United States Hong Kong
Sign in

ASCP PBT: Waived and Point-of-Care Testing: Controls and Troubleshooting

Updated 7 min read
Key takeaway

ASCP PBT candidates should understand that point-of-care testing describes where testing occurs, while waived describes a CLIA complexity category.

  • Use only the test’s approved specimen and follow the manufacturer’s current instructions, including quality-control requirements.
  • If a control is invalid or out of range, stop and follow the troubleshooting process; do not report patient results until the system is acceptable.
On this page7 sections
  1. Point-of-care and waived do not mean the same thing
  2. Controls protect result reliability
  3. A stepwise response to an unacceptable control
  4. Follow manufacturer instructions and the approved specimen type
  5. Troubleshoot without hiding the problem
  6. Practice a control-failure scenario
  7. Study the boundaries of waived testing

Point-of-care and waived do not mean the same thing

Point-of-care testing describes a testing location or workflow, often near the patient. Waived testing describes a CLIA complexity category assigned to a specific test system. The terms can overlap, but they are not synonyms. A test performed near a patient is not automatically waived, and a waived test still has instructions and quality safeguards that staff must follow.

The FDA describes waived tests as the least complex category within CLIA categorization. CMS guidance states that a laboratory with a Certificate of Waiver must follow manufacturer instructions and use only specimen types approved for that waived system. Therefore, candidates should not assume that any sample, operator, location, or modified procedure is acceptable merely because a test is described as simple.

Use the specific test system instructions and current CLIA requirements for details.
Term or eventWhat it meansCandidate response
Point-of-care testingTesting located close to the patient or care siteFollow the test system’s instructions and local quality process.
Waived testA test system categorized as waived under CLIAUse the approved specimen and follow manufacturer instructions.
Control in rangeQuality check meets the manufacturer’s acceptance criteriaProceed as directed by the procedure and document as required.
Control invalid or out of rangeThe test system has not met the required checkStop, troubleshoot, document, and do not report affected patient results.
Patient result appears plausibleA clinical value looks possibleThis does not override a failed control or invalid test state.

Controls protect result reliability

Quality control checks help show whether the testing process is performing within the expected conditions. Depending on the system, controls may assess the test material, reagents, device, operator steps, or a combination of safeguards. The manufacturer’s instructions state when controls are required, how they are run, what counts as acceptable, and what action to take when a check fails.

A patient result is meaningful only when the testing process is valid. A value that seems plausible cannot substitute for an acceptable control. If a control is missing, invalid, or outside its limit, the operator should not release patient results from the affected testing condition. Follow the test’s troubleshooting instructions and notify the responsible person under local policy.

Control testing can also reveal an operator or device problem before a patient result is produced. For instance, a procedural indicator may fail, a reagent may not perform as expected, or an instrument may display an error. Do not assume every system uses the same controls or interval. Read the specific insert and procedure for the test being performed.

External controls are distinct from a built-in procedural control. A built-in control may confirm one part of the test process, while external materials can check other parts of performance. Use what the manufacturer requires and the organization’s quality plan. Do not infer that a visible control line alone covers every needed quality check.

A stepwise response to an unacceptable control

When a control is unacceptable, stop testing patient samples according to the test system instructions. Check the displayed message or control result, identify the exact failure, and consult the current procedure. The next step may involve checking storage, expiration, specimen compatibility, temperature, operator technique, device readiness, or a control material issue. Follow the specified sequence rather than trying random fixes.

Repeat a control only when the instructions or an authorized procedure direct you to do so. Repeatedly testing until a passing value appears can hide a real system problem. If a control remains outside limits or an error persists, escalate to the supervisor or technical support channel specified by the manufacturer. Document the failure, actions, and final resolution.

Do not report patient results generated while the system was in an invalid state unless the official procedure specifically establishes that those results remain valid. FDA’s CLIA waiver guidance says manufacturer labeling should explain invalid results, what to do when control values are out of range, and when results should not be reported. CMS also states that waived laboratories must follow the manufacturer’s QC and test-performance requirements.

If a patient result was already reported before a control failure was discovered, follow the laboratory’s nonconforming-event and result-correction procedure. The operator should promptly notify the appropriate person, preserve the record, and avoid deleting or altering the original result without authorization. Patient notification and follow-up belong to the organization’s approved process.

Follow manufacturer instructions and the approved specimen type

A waived test system is cleared or authorized for particular uses, including certain specimen types and intended populations. The test insert lists these conditions. Do not substitute a different body fluid, collection device, or workflow because it appears similar. CMS guidance states that waived laboratories may only use specimen types approved for that system and must follow its manufacturer requirements.

Manufacturer directions can specify storage, timing, mixing, temperature, reagent preparation, control frequency, and result interpretation. These details can change when a new package insert or device version is released. Use the instructions that match the actual system and lot. A printed procedure should be controlled and current, not a photocopy from an earlier device.

A waived classification does not authorize staff to change the test method. CMS explains that modifying manufacturer instructions can take the system outside its waived status and alter the applicable complexity requirements. Candidates should understand the principle: follow the authorized method, and escalate a situation the instructions do not cover.

Operator training and competency are also part of reliable testing. Read the directions, observe required practice, demonstrate the procedure, and obtain authorization before performing it independently. If an operator is unsure how to interpret a result or error code, ask for guidance rather than improvising. A simple device can still produce a harmful error if used outside its limits.

Troubleshoot without hiding the problem

Start by classifying the issue: control failure, device error, specimen mismatch, reagent problem, invalid result indicator, environmental condition, or operator step. Then follow the matching instructions. The procedure should tell the operator whether to stop, repeat a step, replace a component, contact support, or remove the test system from service. Do not assume one fix applies to every error.

Keep an accurate record. Include the control result or error, relevant lot or device information required by policy, what actions were taken, whom you contacted, and when the system returned to acceptable use. Do not edit a failed control value to make it appear in range. Quality records must reflect what happened so the laboratory can assess whether patient results were affected.

If troubleshooting does not resolve the failure, stop patient testing and seek technical or supervisory direction. A control failure can indicate a problem with the test system, environment, supplies, or technique. Releasing results to avoid delay creates a greater risk than pausing and finding the cause. Communicate anticipated delays through the appropriate clinical channel.

Practice a control-failure scenario

A clinic operator runs the required control before patient testing, and the result is outside the system’s acceptable range. A patient is waiting and the test appears to be a familiar routine. The appropriate response is to stop and follow the manufacturer’s troubleshooting procedure, document the event, and hold patient testing until the system meets the required conditions. The patient’s result should not be reported from an invalid run.

If the first corrective step does not resolve the failure, the operator should continue only as directed or contact the responsible supervisor or manufacturer support. The operator should not repeat controls without limit, choose an acceptable-looking value from a different lot, or change settings without authorization. A credible record preserves the failed result and the steps taken.

This scenario applies the same quality principle as a central laboratory control process: determine whether the method is valid before interpreting a patient value. The device’s location does not change the need for quality safeguards. Waived status does not remove manufacturer instructions or local documentation duties.

Study the boundaries of waived testing

For the exam, learn the difference between test location and complexity category, the purpose of quality control, and the requirement to use a system within its approved instructions. Know the next step when a control fails: stop, troubleshoot, document, and escalate as directed. The exact control interval and acceptance range are device-specific and should not be memorized as universal values.

Do not assume that waived means no quality oversight, no training, or no recordkeeping. CMS issues certificates for laboratories, and the test must be used within the applicable certificate and manufacturer conditions. The precise legal obligations depend on the facility and test, so candidates should use official current CMS and FDA guidance rather than a generic article as regulatory advice.

The ASCP PBT guideline includes waived and point-of-care testing. Check the current guideline linked from ASCP for the exact outline and topic coverage.